These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 36769249)

  • 1. Advanced Glycation End-Products and Diabetic Neuropathy of the Retina.
    Oshitari T
    Int J Mol Sci; 2023 Feb; 24(3):. PubMed ID: 36769249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurovascular Impairment and Therapeutic Strategies in Diabetic Retinopathy.
    Oshitari T
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sulforaphane inhibits advanced glycation end product-induced pericyte damage by reducing expression of receptor for advanced glycation end products.
    Maeda S; Matsui T; Ojima A; Takeuchi M; Yamagishi S
    Nutr Res; 2014 Sep; 34(9):807-13. PubMed ID: 25241332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
    Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S
    Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of Advanced Glycation End Products in the Pathogenesis of Diabetic Retinopathy.
    Xu J; Chen LJ; Yu J; Wang HJ; Zhang F; Liu Q; Wu J
    Cell Physiol Biochem; 2018; 48(2):705-717. PubMed ID: 30025404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of advanced glycation end products in diabetic neuropathy.
    Sugimoto K; Yasujima M; Yagihashi S
    Curr Pharm Des; 2008; 14(10):953-61. PubMed ID: 18473845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AGEs, RAGE, and diabetic retinopathy.
    Zong H; Ward M; Stitt AW
    Curr Diab Rep; 2011 Aug; 11(4):244-52. PubMed ID: 21590515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pathogenesis and Therapeutic Approaches of Diabetic Neuropathy in the Retina.
    Oshitari T
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chrysin Ameliorates Malfunction of Retinoid Visual Cycle through Blocking Activation of AGE-RAGE-ER Stress in Glucose-Stimulated Retinal Pigment Epithelial Cells and Diabetic Eyes.
    Kang MK; Lee EJ; Kim YH; Kim DY; Oh H; Kim SI; Kang YH
    Nutrients; 2018 Aug; 10(8):. PubMed ID: 30096827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication.
    Yamagishi S; Nakamura K; Matsui T; Noda Y; Imaizumi T
    Curr Pharm Des; 2008; 14(5):487-95. PubMed ID: 18289075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy.
    Yamagishi S; Nakamura K; Matsui T
    Curr Drug Discov Technol; 2006 Mar; 3(1):83-8. PubMed ID: 16712466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
    Khalid M; Petroianu G; Adem A
    Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AGEs and diabetic retinopathy.
    Stitt AW
    Invest Ophthalmol Vis Sci; 2010 Oct; 51(10):4867-74. PubMed ID: 20876889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advanced glycation end products induce immature angiogenesis in in vivo and ex vivo mouse models.
    Chen L; Cui Y; Li B; Weng J; Wang W; Zhang S; Huang X; Guo X; Huang Q
    Am J Physiol Heart Circ Physiol; 2020 Mar; 318(3):H519-H533. PubMed ID: 31922896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association analysis of -429T/C receptor for advanced glycation end products (RAGE) gene polymorphism with type 2 diabetic retinopathy and serum soluble RAGE levels in Pakistani patients.
    Qayyum S; Afzal M; Naveed AK
    J Pak Med Assoc; 2021 Apr; 71(4):1175-1180. PubMed ID: 34125766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products and diabetic retinopathy.
    Chen M; Curtis TM; Stitt AW
    Curr Med Chem; 2013; 20(26):3234-40. PubMed ID: 23745547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between accumulation of advanced glycation end products and expression of vascular endothelial growth factor in human diabetic retinas.
    Murata T; Nagai R; Ishibashi T; Inomuta H; Ikeda K; Horiuchi S
    Diabetologia; 1997 Jul; 40(7):764-9. PubMed ID: 9243096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advanced glycation end-products: a review.
    Singh R; Barden A; Mori T; Beilin L
    Diabetologia; 2001 Feb; 44(2):129-46. PubMed ID: 11270668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced glycation and advanced lipoxidation: possible role in initiation and progression of diabetic retinopathy.
    Stitt AW; Frizzell N; Thorpe SR
    Curr Pharm Des; 2004; 10(27):3349-60. PubMed ID: 15544520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of advanced glycation in the pathogenesis of diabetic retinopathy.
    Stitt AW
    Exp Mol Pathol; 2003 Aug; 75(1):95-108. PubMed ID: 12834631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.